论文部分内容阅读
目的:分析米非司酮和米索前列醇联合依沙吖啶终止中期妊娠患者的临床效果。方法:选取进行终止中期妊娠患者45例分成实验组(23例)和对照组(22例),对照组单纯采取依沙吖啶进行治疗,实验组在对照组患者基础上联合米非司酮和米索前列醇进行治疗。结束后观察两种治疗方法的临床效果。结果:两组患者在宫缩发动时间(X2=5.63,P<0.05)、疼痛情况(X2=6.43,P<0.05)、产程时间(X2=3.79,P<0.05)及产中出血量(X2=4.39,P<0.05)差异显著,实验组终止妊娠效果较为满意。结论:采取米非司酮和米索前列醇联合依沙吖啶对中期妊娠患者进行终止,安全性高,适合在临床上推广使用。
OBJECTIVE: To analyze the clinical effect of mifepristone and misoprostol combined with ethacridine in terminating midterm pregnancy. Methods: 45 cases were divided into experimental group (23 cases) and control group (22 cases). The control group was treated with ethacridine alone. The experimental group was treated with mifepristone and Misoprostol for treatment. After the end of the observation of the clinical efficacy of the two treatment methods. Results: The duration of labor (X2 = 3.79, P <0.05) and the amount of bleeding during labor (X2 = 5.63, P <0.05) = 4.39, P <0.05) significant difference, the experimental group termination of pregnancy is more satisfactory. Conclusion: Mifepristone and misoprostol combined with ethacridine termination of midterm pregnancy, high safety, suitable for clinical use.